Amnioinfusion

in initial attempts (eg, use of amnioinfusion to enhance fetal visualization, use of fetal paralysis, routine use of antibiotics, and increased focus on proper catheter placement), as well as specific outcome measures needed for appropriate evaluation of the effects of fetal intervention (eg, gross survival, postnatal survival, shunted survival, and nadir creatinine at 1 year). [ ] Laparoscopy has also been described but has been associated with high rates of complications. [ ] Fetal cystoscopic ablation (...) of posterior urethral valves has been described; success rates have varied. [ ] The fetoscope is passed percutaneously through a cannula into the fetal bladder, and ablation of the valves is achieved with laser coagulation. Other less invasive techniques have been developed to help prevent oligohydramnios-induced pulmonary hypoplasia. As previously mentioned, serial transabdominal amnioinfusion is helpful in placement of percutaneous shunts. It may also have a therapeutic role in the reduction of pulmonary

, Length of rupture of membranes, Number of vaginal examinations, Use of internal monitoring, Meconium, Use of antenatal steroids, cervical dilators, vacuum, amnioinfusion, extraamniotic saline infusion. Type of section, Anaesthesia type, Uterine incision type, Uterine closure layers, Uterine incision extensions, Need for transfusion, Intraoperative blood loss, Time of day, Operative time, Deviation from the standard surgical procedure. Birth weight (gram), Gestational age (week Eligibility Criteria Go

in case selection and outcomes between the centers. After controlling for the center of surgery, multivariate analysis indicated that a lower maternal age at procedure, a history of previous prematurity, shortened cervical length, use of amnioinfusion, a cannula diameter of 12 French (Fr), lack of a collagen plug placement and iatrogenic preterm premature rupture of membranes (iPPROM) were significantly associated with a lower gestational age at delivery.Specific fetal/maternal and operative variables

selection strategies were obesity, induction/augmentation of labor, twins, hydramnios, anemia, and arrest of descent. Amnioinfusion appeared to be protective against uterine atony (OR, 0.53; 95% CI, 0.29-0.98).Independent risk factors for uterine atony requiring treatment include Hispanic and non-Hispanic white ethnicity, preeclampsia, and chorioamnionitis.Copyright © 2013 Mosby, Inc. All rights reserved.

) syndrome, other end-organ affliction or Central Nervous System (CNS) findings other than mild headache; Fetal malpresentation; Diagnosed congenital anomalies, not including polydactyly; Any evidence of fetal compromise at baseline (e.g., non-reassuring fetal heart rate pattern or meconium staining); Amnioinfusion or other treatment of non-reassuring fetal status at any time prior to the induction attempt; Ruptured membranes ≥ 48 hours prior to the start of treatment; Suspected chorioamnionitis; Fever

in case of kidney failure. . Failure of one kidney to form occurs in approximately one in 750 live births. Failure of both kidneys to form used to be fatal; however, medical advances such as amnioinfusion therapy during pregnancy and peritoneal dialysis have made it possible to stay alive until a transplant can occur. Unilateral small kidney occurs in approximately one in every 2400 live births Ureteropelvic Junction Obstruction or UPJO; although most cases are congenital, some are acquired. Diagnosis

fetal heart rate pattern or meconium staining); Amnioinfusion or other treatment of non-reassuring fetal status at any time prior to the induction attempt; Ruptured membranes ≥ 48 hours prior to the start of treatment; Suspected chorioamnionitis; Fever (oral or aural temperature > 37.5°C); Any condition in which vaginal delivery is contraindicated e.g., placenta previa or any unexplained genital bleeding at any time after 24 weeks during this pregnancy; Known or suspected allergy to misoprostol

pooling in the vagina after amnioinfusion; or visible leakage of amniotic fluid from the cervix) B. Rupture of the membranes in the presence of more than 6 contractions per hour or cervical dilation of 3 cm or more, unless oxytocin was withheld for at least 12 hours (other induction agents allowed) C. Chorioamnionitis - exclude if patient is diagnosed with chorioamnionitis D. Cervical dilation ≥ 8 cm E. Evidence of non-reassuring fetal status requiring immediate delivery Participation in another

to achieve adequate enteral nutrition as soon as possible. Because LR is a an amniotic fluid-like solution, it may improve gastro-intestinal function and avoid fasting, as well as its multiple problems (e.g. intestinal atrophy and decreased intestinal motility). LR was chosen as the test solution because of experience documenting its safe use in comparable groups: in newborn resuscitation parenterally, in amnioinfusion, and in bowel irrigation. Moreover, LR is similar in electrolytes composition

of amnioinfusion (AI) for the prevention of MAS among women with thick-consistency MSAF. MAS was defined as onset of respiratory distress requiring oxygen supplementation within the first 4 hours of life. Patients with respiratory symptoms with onset at >or=4 hours were treated as a separate outcome category, "late-onset respiratory distress." We developed peripartum and intrapartum regression models to identify the risk of MAS and its subgroups. A tracing with marked abnormalities was a significant risk

who had undergone RFA, in a 2 : 1 ratio, controlling for gestational age and indication. The primary outcome was fetal survival.Twenty patients in the RFA group were matched with 40 patients in the BPC group. Fewer additional intra-operative procedures were performed in the RFA group compared with the BPC group: amnioinfusion, 10% vs. 75%, respectively (P < 0.01); and amnioreduction, 5% vs. 40%, respectively (P = 0.004). The overall survival rates were 87.5% in the RFA group and 88% in the BPC

Amnioinfusion for relief of recurrent severe and moderate variable decelerations in labor. To determine whether intrapartum amnioinfusion (AI) relieves recurrent moderate and severe variable decelerations in laboring women with clear or grade I meconium-stained amniotic fluid and reduces cesarean section rate for fetal distress.A randomized controlled trial was conducted in labor unit of Christian Medical College Hospital, Vellore, India, between October 2003 and September 2004. Women were

at term.To assess the effects of routine tocolysis, fetal acoustic stimulation, epidural or spinal analgesia and transabdominal amnioinfusion for external cephalic version at term on successful version and measures of pregnancy outcome.The Cochrane Pregnancy and Childbirth Group trials register (September 2003) and the Cochrane Central Register of Controlled Trials (The Cochrane Library, Issue 3, 2003) were searched.Randomised and quasi-randomised trials comparing routine versus selective or no tocolysis (...) ; fetal acoustic stimulation in midline fetal spine positions versus dummy or no stimulation; epidural or spinal analgesia versus no regional analgesia; or transabdominal amnioinfusion versus no amnioinfusion for external cephalic version at term.The reviewer assessed eligibility and trial quality.In six trials, routine tocolysis with beta-stimulants was associated with fewer failures of external cephalic version (relative risk (RR) 0.74, 95% confidence interval (CI) 0.64 to 0.87). The reduction

assessment with electronic fetal monitoring (EFM) is recommended. If meconium and variable decelerations are present, then consider amnioinfusion. If the woman has meconium stained liquor and a non-reassuring EFM tracing and is in a facility without operating room (OR) capability, then transfer to a facility with OR capability should be considered. Be prepared for shoulder dystocia and neonatal resuscitation at delivery (See Newborn Guideline 7: Newborn Resuscitation, Resources and Education). REFERENCES

External cephalic version facilitation for breech presentation at term. Successful external cephalic version at a late stage of pregnancy was considered to be possible only with the use of tocolytic drugs to relax the uterus. Other methods are also used in an attempt to facilitate external cephalic version at term.The objective of this review was to assess the effects of routine tocolysis, fetal acoustic stimulation, epidural anaesthesia and transabdominal amnioinfusion for external cephalic (...) version at term on successful version and measures of pregnancy outcome.The Cochrane Pregnancy and Childbirth Group trials register and the Cochrane Controlled Trials Register were searched. Date of last search: February 1999.Randomised and quasi-randomised trials comparing routine versus selective tocolysis; fetal acoustic stimulation in midline fetal spine positions versus dummy or no stimulation; epidural analgesia versus no epidural analgesia; or transabdominal amnioinfusion versus

of digoxin amnioinfusion, participants received a randomly allocated, identical-appearing capsule containing either mifepristone, 200 mg, or placebo. Patients returned the following day for induction with buccal misoprostol. The primary outcome was the time interval from the first misoprostol dose to abortion. Analysis utilized survival curves with log-rank testing. RESULTS: Of 64 women, 32 received mifepristone and 32 received placebo. The groups did not differ by ethnicity, age, parity, reason

between the ages of 18 and 45 years Gestational ages 15 - 24 weeks Exclusion Criteria: Multiple gestation Refusal to participate in the trial Known hypersensitivity to lidocaine Amniocentesis during this pregnancy Amnioinfusion/amnioreduction where the procedure is likely to be prolonged Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided

index was obtained in 499 pregnancies, and the 2 x 1 technique was performed in 501. Oligohydramnios was diagnosed in 25% of amniotic fluid index pregnancies versus 8% with the use of the 2 x 1 pocket technique (P <.001). Both techniques failed to identify patients who underwent an amnioinfusion for fetal distress (P=.864) or who experienced variable (P=.208) or late decelerations (P=.210) that influenced delivery, fetal distress in labor (P=.220), caesarean delivery for fetal distress (P=.133

Abnormal fetal heart rate tracing patterns in patients with thick meconium staining of the amniotic fluid: association with perinatal outcomes. The objective of the study was to evaluate, in labors complicated by thick meconium-stained amniotic fluid, the association between specific fetal heart rate (FHR) patterns and adverse perinatal outcomes.A retrospective cohort study of patients with FHR tracing data (n = 1638) from a previously reported randomized controlled trial of amnioinfusion